A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.
Clinical trial NCT00576901 · TERMINATED
Trial details
- NCT number
- NCT00576901
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-06-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.